Market Highlights
With the growing awareness of early diagnosis, advanced treatment and growing novel drugs to treat the women health disorders among the patients and healthcare professionals has supported the growth of the market. The health of women is of particular concern as in many societies women are disadvantaged by discrimination rooted in sociocultural factors. For instance, women and girls face increased vulnerability to HIV/AIDS
Globally, women healthcare market share is dominated by several major players such as Allergan, Amgen, Bayer, BD, Eli Lily, Merck, Pfizer, Teva Pharmaceuticals and others. APAC region was the most benefited region due to the rising prevalence of the disease and rising number of treatment for women associated diseases and increasing advanced devices and therapeutics for gynecological disorders. The market for women healthcare is projected to grow at a steady CAGR of 4.10% during the forecast period from 2022-2030.
Global Women Healthcare Market Players:
Market players profiled in the report are Allergan plc. (Ireland), Amgen (California), Bayer A G (Germany), Becton Dickinson and Company (U.S.), Eli Lilly Company (U.S.), Merck Co., Inc., (U.S.), Pfizer Inc., (U.S.), and Teva Pharmaceuticals (Israel).
The Women Healthcare Market has turned into a critical factor in the Global Healthcare industry. Through extensive research it is found out that the market players are investing in the research and development of new and novel drugs for the treatment of various women health disorders and receiving FDA approvals for the drugs and devices in the women healthcare market. The key players involved in this FDA approvals are Bayer AG, Becton, Dickinson and Company, Pfizer Inc. and Teva Pharmaceuticals. FDA approvals (32%) is the most widely opted strategy which was adopted by the key market players. The number of key market player involved in Clinical Trials (23%), Product Launch (18%), Awards Recognition (14%), Agreements Collaboration (9%) and others are comparatively low, the market players which were involved in Clinical Trials are Allergan, Bayer, Eli Lily, AbbVie and others in the Global Women Healthcare Market.
Test the market data and market information presented through more than 50 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content (TOC) market synopsis on “Global Women Healthcare Market” Research Report – Forecast to 2023.
Segmentation:
The Women Healthcare Market is segmented on the basis of indications, diagnosis and treatment and also on the basis of end users. Based on the indications, the market has been segmented as postmenopausal osteoporosis, infertility, reproductive health management, polycystic ovary syndrome, gynecologic cancer and others. Gynecologic cancer segment has been further divided into breast, ovarian or other types of cancer. On the basis of diagnosis the market has been segmented as bone densitometry, diagnostic imaging tests, biopsies, ovulation testing and others. Similarly, on the basis of treatment the market has been classified as therapeutics, surgeries and others. Lastly on the basis of end users the market has been further classified into hospitals clinics, gynecology centers, research institutes, and others
Get Full Report: https://www.marketresearchfuture.com/reports/women-healthcare-market-3121
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
